BofA/Merrill Lynch Downgrades Roche (RHHBY) to Neutral
Tweet
Share
E-mailGet Alerts RHHBY Hot Sheet
Price: $54.58 +0.11%
Rating Summary:
5 Buy, 8 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 20
Rating Summary:
5 Buy, 8 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 20
Join SI Premium – FREE
BofA/Merrill Lynch analyst Graham Perry downgraded Roche (OTC: RHHBY) from Buy to Neutral with a price target of $34.00 (from $35.00).
For an analyst ratings summary and ratings history on Roche click here. For more ratings news on Roche click here.
Shares of Roche closed at $30.67 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Enovix Corporation (ENVX) PT Lowered to $5 at BofA Securities
- Candel Therapeutics Inc. (CADL) PT Raised to $15 at Freedom Broker
- Voltas Ltd. (VOLT:IN) PT Lowered to INR1,357 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
